{
  "id": "CG-EX:CritAssess288",
  "type": "CriterionAssessment",
  "criterion": {
    "id": "SEPIO-CG:99026",
    "type": "Criterion",
    "label": "PS4",
    "description": "The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls",
    "defaultStrength": {
      "id": "SEPIO:0000330",
      "type": "EvidenceLineStrength",
      "label": "Pathogenic Strong"
    }
  },
  "variant": {
    "id": "CAR:CA024311",
    "type": "CanonicalAllele",
    "preferredCtxAllele": {
      "id": "CG-EX:CtxAll026",
      "type": "ContextualAllele",
      "relatedCanonicalAllele": "CanAll023",
      "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
    }
  },
  "condition": [
    {
      "id": "CG-EX:GenCond011",
      "type": "GeneticCondition",
      "disease": [
        {
          "id": "Orphanet:423",
          "type": "Disease",
          "label": "Malignant hyperthermia"
        }
      ],
      "modeOfInheritance": {
        "id": "HP:0000006",
        "type": "ModeOfInheritance",
        "label": "Autosomal Dominant"
      }
    }
  ],
  "outcome": {
    "id": "SEPIO:0000223",
    "type": "CriterionEvaluation",
    "label": "Met"
  },
  "evidenceLine": [
    {
      "id": "CG-EX:EvLn020",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "CG-EX:CaseCtrl033",
          "type": "CaseControl",
          "canonicalAllele": {
            "id": "CAR:CA024311",
            "type": "CanonicalAllele",
            "preferredCtxAllele": {
              "id": "CG-EX:CtxAll026",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CanAll023",
              "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
            }
          },
          "condition": {
            "id": "CG-EX:GenCond011",
            "type": "GeneticCondition",
            "disease": [
              {
                "id": "Orphanet:423",
                "type": "Disease",
                "label": "Malignant hyperthermia"
              }
            ],
            "modeOfInheritance": {
              "id": "HP:0000006",
              "type": "ModeOfInheritance",
              "label": "Autosomal Dominant"
            }
          },
          "caseGroupFrequency": {
            "id": "CG-EX:AllFreq032",
            "type": "AlleleFrequency",
            "allele": {
              "id": "CAR:CA024311",
              "type": "CanonicalAllele",
              "preferredCtxAllele": {
                "id": "CG-EX:CtxAll026",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll023",
                "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
              }
            },
            "description": "This allele is thought to account for between 2% and 10% of patients with Malignant hyperthermia."
          },
          "controlGroupFrequency": {
            "id": "CG-EX:AllFreq031",
            "type": "AlleleFrequency",
            "ascertainment": {
              "id": "SEPIO:0000332",
              "type": "Ascertainment",
              "label": "ExAc ascertainment method"
            },
            "allele": {
              "id": "CAR:CA024311",
              "type": "CanonicalAllele",
              "preferredCtxAllele": {
                "id": "CG-EX:CtxAll026",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll023",
                "alleleName": "NM_000540.2 (RYR1):c.1840C>T"
              }
            },
            "alleleCount": 9,
            "alleleNumber": 66740
          },
          "description": "Did not calculate formal odds ratio"
        }
      ]
    }
  ],
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "CG-EX:Agent001",
        "type": "Agent",
        "label": "Harry Stevenson"
      },
      "contributionDate": "6/5/16 2:39 PM",
      "contributionRole": {
        "id": "SEPIO:0000154",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ],
  "description": "Across publications, this variant is thought to account for 2%-10% of patients with Malignant hyperthermia. But variant is also only found in 9/66740 Europeans in ExAC (.01%). Based on these differences, groups applied PS4 to this variant classification (without a formal OR analysis).",
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
